Bullboard - Stock Discussion Forum Bausch Health Companies Inc T.BHC

Alternate Symbol(s): BHC

Healthcare

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with... see more

Add To Watchlist

TSX:BHC - Post Discussion

Bausch Health Companies Inc > Earnings Report 📑🧐

View:

Post by Duster340 on Jul 31, 2024 12:42pm

Earnings Report 📑🧐

i would not touch this with a 10 foot pole.

Bausch Health Companies (NYSE:BHC) is scheduled to announce Q2 earnings results on Thursday, August 1st, before market open.
The consensus EPS Estimate is $0.88 and the consensus Revenue Estimate is $2.34B (+7.8% Y/Y).
Over the last 2 years, BHC has beaten EPS estimates 25% of the time and has beaten revenue estimates 25% of the time.
Over the last 3 months, EPS estimates have seen 1 upward revision and 4 downward. Revenue estimates have seen 2 upward revisions and 2 downward.
Recent earnings Analysis from our contributors:2 Red Alerts On Bausch Health Companies